Ontology highlight
ABSTRACT: Background
Amyloid-beta (Aβ) plaque is a neuropathological hallmark of Alzheimer's disease (AD). As anti-amyloid monoclonal antibodies enter the market, predicting brain amyloid status is critical to determine treatment eligibility.Objective
To predict brain amyloid status utilizing machine learning approaches in the Advancing Reliable Measurement in Alzheimer's Disease and Cognitive Aging (ARMADA) study.Design
ARMADA is a multisite study that implemented the National Institute of Health Toolbox for Assessment of Neurological and Behavioral Function (NIHTB) in older adults with different cognitive ability levels (normal, mild cognitive impairment, early-stage dementia of the AD type).Setting
Participants across various sites were involved in the ARMADA study
SUBMITTER: Cheng Y
PROVIDER: S-EPMC11269772 | biostudies-literature | 2024
REPOSITORIES: biostudies-literature